BioCryst: Q3 Earnings Snapshot
By AP News
Published - Nov 04, 2024, 07:06 AM ET
Last Updated - Dec 16, 2024, 05:43 PM EST
DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $14 million in its third quarter.
The Durham, North Carolina-based company said it had a loss of 7 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 7 cents per share.
The drugmaker posted revenue of $117.1 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $114.8 million.
